CDC25C and neoplasm: Higher levels of immuno-stimulators and lower levels of immuno-inhibitors in low CDC25C LUAD could promote enhanced anti-tumor immunity, supporting prolonged survival of patients with low CDC25C. MHC molecules, playing an essential role in antigen presentation, are indispensable in the recognizing and killing of tumor cells by immune cells (50).